Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
BMC Genomics ; 24(1): 76, 2023 Feb 17.
Article in English | MEDLINE | ID: covidwho-2288710

ABSTRACT

Since genes do not function individually, the gene module is considered an important tool for interpreting gene expression profiles. In order to consider both functional similarity and expression similarity in module identification, GMIGAGO, a functional Gene Module Identification algorithm based on Genetic Algorithm and Gene Ontology, was proposed in this work. GMIGAGO is an overlapping gene module identification algorithm, which mainly includes two stages: In the first stage (initial identification of gene modules), Improved Partitioning Around Medoids Based on Genetic Algorithm (PAM-GA) is used for the initial clustering on gene expression profiling, and traditional gene co-expression modules can be obtained. Only similarity of expression levels is considered at this stage. In the second stage (optimization of functional similarity within gene modules), Genetic Algorithm for Functional Similarity Optimization (FSO-GA) is used to optimize gene modules based on gene ontology, and functional similarity within gene modules can be improved. Without loss of generality, we compared GMIGAGO with state-of-the-art gene module identification methods on six gene expression datasets, and GMIGAGO identified the gene modules with the highest functional similarity (much higher than state-of-the-art algorithms). GMIGAGO was applied in BRCA, THCA, HNSC, COVID-19, Stem, and Radiation datasets, and it identified some interesting modules which performed important biological functions. The hub genes in these modules could be used as potential targets for diseases or radiation protection. In summary, GMIGAGO has excellent performance in mining molecular mechanisms, and it can also identify potential biomarkers for individual precision therapy.


Subject(s)
COVID-19 , Gene Regulatory Networks , Humans , Gene Ontology , Algorithms , Gene Expression Profiling/methods , Transcriptome
2.
ACM Computing Surveys ; 55(8):1940/01/01 00:00:00.000, 2023.
Article in English | Academic Search Complete | ID: covidwho-2234993

ABSTRACT

The bioinformatics discipline seeks to solve problems in biology with computational theories and methods. Formal concept analysis (FCA) is one such theoretical model, based on partial orders. FCA allows the user to examine the structural properties of data based on which subsets of the dataset depend on each other. This article surveys the current literature related to the use of FCA for bioinformatics. The survey begins with a discussion of FCA, its hierarchical advantages, several advanced models of FCA, and lattice management strategies. It then examines how FCA has been used in bioinformatics applications, followed by future prospects of FCA in those areas. The applications addressed include gene data analysis (with next-generation sequencing), biomarkers discovery, protein-protein interaction, disease analysis (including COVID-19, cancer, and others), drug design and development, healthcare informatics, biomedical ontologies, and phylogeny. Some of the most promising prospects of FCA are identifying influential nodes in a network representing protein-protein interactions, determining critical concepts to discover biomarkers, integrating machine learning and deep learning for cancer classification, and pattern matching for next-generation sequencing. [ FROM AUTHOR]

3.
Acm Computing Surveys ; 55(8), 2023.
Article in English | Web of Science | ID: covidwho-2194084

ABSTRACT

The bioinformatics discipline seeks to solve problems in biology with computational theories and methods. Formal concept analysis (FCA) is one such theoretical model, based on partial orders. FCA allows the user to examine the structural properties of data based on which subsets of the dataset depend on each other. This article surveys the current literature related to the use of FCA for bioinformatics. The survey begins with a discussion of FCA, its hierarchical advantages, several advanced models of FCA, and lattice management strategies. It then examines how FCA has been used in bioinformatics applications, followed by future prospects of FCA in those areas. The applications addressed include gene data analysis (with next-generation sequencing), biomarkers discovery, protein-protein interaction, disease analysis (including COVID-19, cancer, and others), drug design and development, healthcare informatics, biomedical ontologies, and phylogeny. Some of the most promising prospects of FCA are identifying influential nodes in a network representing protein-protein interactions, determining critical concepts to discover biomarkers, integrating machine learning and deep learning for cancer classification, and pattern matching for next-generation sequencing.

4.
2021 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2021 ; : 556-561, 2021.
Article in English | Scopus | ID: covidwho-1722878

ABSTRACT

Clinical omics, especially gene expression data, have been widely studied and successfully applied for disease diagnosis using machine learning techniques. As genes often work interactively rather than individually, investigating co-functional gene modules can improve our understanding of disease mechanisms and facilitate disease state prediction. To this end, we in this paper propose a novel Multi-Level Enhanced Graph ATtention (MLE-GAT) network to explore the gene modules and intergene relational information contained in the omics data. In specific, we first format the omics data of each patient into co-expression graphs using weighted correlation network analysis (WGCNA) and then feed them to a well-designed multi-level graph feature fully fusion (MGFFF) module for disease diagnosis. For model interpretation, we develop a novel full-gradient graph saliency (FGS) mechanism to identify the disease-relevant genes. Comprehensive experiments show that our proposed MLE-GAT achieves state-of-the-art performance on transcriptomics data from TCGA-LGG/TCGA-GBM and proteomics data from COVID-19/non-COVID-19 patient sera. © 2021 IEEE.

SELECTION OF CITATIONS
SEARCH DETAIL